NL-OMON25449招募中不适用
Evaluating patient reported outcomes in the treatment practice of patients with rheumatoid arthritis
none0 个研究点目标入组 300 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 300
研究概览
简要总结
/A
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Adults with reumatoïde artritis treated with biologicals, such as TNFα-blockers (etanercept, adalimumab, infliximab etc.), interleukine-I-blockers, the B-celblocker rituximab, and the T-celactivationblocker and anti CTLA4 (abatacept).
排除标准
- •non RA patients, no biological treatment, non adult,
研究者
相似试验
尚未招募
Unknown
Assessing patient reported outcome and clinical severity in patients with Oral Lichen PlanusCTRI/2024/01/061185Dr Lakshmi Priya
招募中
1 期
Evaluation of outcomes of oncoplastic techniques in surgery of breast cancerIRCT20111207008316N4Mashhad University of Medical Sciences60
进行中（未招募）
不适用
An Evaluation of Patient Reported Outcomes and Ocular Surface Health in Patients Using DuoTrav APS Eye Drops Solution Versus XALACOM® Eye Drops Solution - DuoTrav APS versus XALACOM® in Patient Reported Outcomes and Ocular Surface HealthEUCTR2009-010604-29-BEAlcon Research, Ltd.400
已完成
3 期
An Evaluation of Patient Reported Outcomes and Ocular Surface Health in Patients Using DuoTrav APS Eye Drops Solution Versus XALACOM® Eye Drops Solution.raised intra-ocular pressure with optic nerve damageraised intra-ocular pressure without optic nerve damage10018307NL-OMON35130Alcon Laboratories30
进行中（未招募）
不适用
An Evaluation of Patient Reported Outcomes and Ocular Surface Health in Patients Using Travoprost APS Eye Drops Solution Versus XALATAN Eye Drops Solution - Travoprost APS versus XALATAN in OSDIOpen Angle Glaucoma or Ocular HypertensionMedDRA version: 9.1Level: LLTClassification code 10030043Term: Ocular hypertensionMedDRA version: 9.1Level: LLTClassification code 10030348Term: Open angle glaucomaEUCTR2009-010606-10-GBAlcon Research, Ltd.516